Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BINAP. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN109836408A enables high-yield binaphthyl crown ether production. Offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN115504885A details a novel 4-step synthesis for chiral pillararene derivatives with superior circularly polarized luminescence, offering cost-effective manufacturing solutions.
Patent CN108329194B reveals a novel binaphthol aluminum catalyst for citronellal cyclization, offering superior enantioselectivity and simplified industrial recovery.
Discover a scalable synthesis route for chiral binaphthalene dicarboxylic acid via patent CN101781197A. Achieve >99% optical purity and significant cost reduction in pharma intermediate manufacturing.
Patent CN112811996B details a metal-free catalytic method for synthesizing chiral ketones with high enantioselectivity, offering cost-effective solutions for pharmaceutical intermediates.
Patent CN115521193A reveals a copper-lithium mediated synthesis improving yield and reducing waste for high-purity OLED intermediates.
Patent CN102464681A discloses a stable chiral bidentate phosphite ligand for asymmetric synthesis, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN108329194A reveals high-selectivity isopulegol production. Enhances supply chain stability and reduces manufacturing costs significantly.
Novel asymmetric Mannich catalyst synthesis via eco-friendly oxygen oxidation. Delivers high ee values for beta-amino carbonyls. Reliable supply chain solution.
Discover the novel synthesis of chiral binaphthyl-aza ligands from patent CN112142638A. Achieve high enantioselectivity with scalable, cost-effective manufacturing processes.
Patent CN112194685A reveals high-yield synthesis for chiral catalysts. Enhance supply chain reliability and reduce manufacturing costs with scalable processes.
Patent CN114920702A discloses a metal-free asymmetric conjugate addition method for synthesizing optically active imidazolone compounds with high enantioselectivity and yield.
Novel synthesis method for azacycle-derived polyarylmethane antitumor compounds offering mild conditions and high cytotoxic activity for pharmaceutical supply chains.
Patent CN108069835A reveals photocatalytic route for chiral helicenes. Offers cost reduction and supply chain reliability for asymmetric catalysis intermediates.
Patent CN120247882B reveals mild synthesis for antitumor compounds. Achieve cost reduction in pharmaceutical manufacturing with scalable, high-purity routes.
Novel binaphthyl phosphoric acid catalyzed synthesis of isoindolinone imines. High yield, mild conditions, suitable for commercial scale-up in pharmaceutical manufacturing.
Patent CN113957461B reveals metal-free electrochemical route for 1,1'-binaphthyl. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN118878452B reveals novel antitumor compound synthesis. Offers mild conditions and high yield for pharmaceutical intermediate supply chains. Enables cost reduction in API manufacturing.
Patent CN120247882B reveals mild synthesis for antitumor compounds. Enables cost reduction in pharmaceutical manufacturing and high-purity API supply chain reliability.
Patent CN118878452B reveals a mild catalytic route for anti-tumor intermediates. This report analyzes supply chain stability and cost reduction in pharma manufacturing.